Invesco’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.3M | Sell |
182,002
-71,809
| -28% | -$963K | ﹤0.01% | 2482 |
|
|
2025
Q4 | $4M | Buy |
253,811
+194,113
| +325% | +$2.47M | ﹤0.01% | 2346 |
|
|
2025
Q3 | $715K | Sell |
59,698
-3,186
| -5% | -$25.5K | ﹤0.01% | 3084 |
|
|
2025
Q2 | $475K | Buy |
62,884
+2,607
| +4% | +$15.7K | ﹤0.01% | 3175 |
|
|
2025
Q1 | $333K | Buy |
60,277
+13,663
| +29% | +$84.4K | ﹤0.01% | 3320 |
|
|
2024
Q4 | $268K | Buy |
46,614
+3,186
| +7% | +$30.5K | ﹤0.01% | 3450 |
|
|
2024
Q3 | $450K | Buy |
43,428
+64
| +0.1% | +$837 | ﹤0.01% | 3277 |
|
|
2024
Q2 | $562K | Sell |
43,364
-135
| -0.3% | -$1.82K | ﹤0.01% | 3226 |
|
|
2024
Q1 | $759K | Buy |
43,499
+23,267
| +115% | +$308K | ﹤0.01% | 3123 |
|
|
2023
Q4 | $190K | Buy |
20,232
+1,666
| +9% | +$15.5K | ﹤0.01% | 3580 |
|
|
2023
Q3 | $207K | Sell |
18,566
-65,557
| -78% | -$1.06M | ﹤0.01% | 3579 |
|
|
2023
Q2 | $1.8M | Sell |
84,123
-217,647
| -72% | -$6.42M | ﹤0.01% | 2667 |
|
|
2023
Q1 | $12.2M | Buy |
301,770
+195,171
| +183% | +$9.32M | ﹤0.01% | 1641 |
|
|
2022
Q4 | $4.96M | Sell |
106,599
-249,578
| -70% | -$11.4M | ﹤0.01% | 2252 |
|
|
2022
Q3 | $18.5M | Sell |
356,177
-143,353
| -29% | -$8.38M | 0.01% | 1376 |
|
|
2022
Q2 | $23.6M | Buy |
499,530
+157,523
| +46% | +$8.55M | 0.01% | 1269 |
|
|
2022
Q1 | $24.3M | Buy |
342,007
+52,163
| +18% | +$3.39M | 0.01% | 1389 |
|
|
2021
Q4 | $21.7M | Buy |
289,844
+183,676
| +173% | +$14.4M | 0.01% | 1500 |
|
|
2021
Q3 | $6.03M | Sell |
106,168
-174,996
| -62% | -$8.65M | ﹤0.01% | 2286 |
|
|
2021
Q2 | $12.4M | Sell |
281,164
-44,392
| -14% | -$2.17M | ﹤0.01% | 1921 |
|
|
2021
Q1 | $16.1M | Sell |
325,556
-237,655
| -42% | -$11.9M | ﹤0.01% | 1682 |
|
|
2020
Q4 | $23.7M | Buy |
563,211
+27,996
| +5% | +$1.23M | 0.01% | 1344 |
|
|
2020
Q3 | $24.5M | Buy |
535,215
+419,312
| +362% | +$20.3M | 0.01% | 1212 |
|
|
2020
Q2 | $5.82M | Sell |
115,903
-120,441
| -51% | -$6.23M | ﹤0.01% | 1914 |
|
|
2020
Q1 | $12.2M | Sell |
236,344
-151,095
| -39% | -$8.05M | 0.01% | 1444 |
|
|
2019
Q4 | $23.9M | Buy |
387,439
+57,499
| +17% | +$3.56M | 0.01% | 1325 |
|
|
2019
Q3 | $19.8M | Buy |
329,940
+19,223
| +6% | +$1.43M | 0.01% | 1416 |
|
|
2019
Q2 | $26.2M | Sell |
310,717
-102,610
| -25% | -$9.23M | 0.01% | 1297 |
|
|
2019
Q1 | $39.5M | Sell |
413,327
-45,629
| -10% | -$4.09M | 0.01% | 920 |
|
|
2018
Q4 | $32.5M | Sell |
458,956
-248,157
| -35% | -$19M | 0.01% | 934 |
|
|
2018
Q3 | $60.4M | Buy |
707,113
+198,572
| +39% | +$19.9M | 0.02% | 794 |
|
|
2018
Q2 | $58.9M | Buy |
508,541
+35,313
| +7% | +$3.52M | 0.02% | 779 |
|
|
2018
Q1 | $38.3M | Sell |
473,228
-73,471
| -13% | -$5.65M | 0.01% | 860 |
|
|
2017
Q4 | $32.1M | Sell |
546,699
-156,761
| -22% | -$7.85M | 0.01% | 963 |
|
|
2017
Q3 | $32.9M | Buy |
703,460
+622,323
| +767% | +$25M | 0.01% | 948 |
|
|
2017
Q2 | $2.92M | Buy |
81,137
+3,338
| +4% | +$107K | ﹤0.01% | 2281 |
|
|
2017
Q1 | $2.4M | Buy |
77,799
+19,033
| +32% | +$593K | ﹤0.01% | 2461 |
|
|
2016
Q4 | $1.97M | Buy |
58,766
+8,333
| +17% | +$239K | ﹤0.01% | 2590 |
|
|
2016
Q3 | $1.34M | Sell |
50,433
-10,608
| -17% | -$246K | ﹤0.01% | 2796 |
|
|
2016
Q2 | $1.35M | Sell |
61,041
-8,713
| -12% | -$228K | ﹤0.01% | 2727 |
|
|
2016
Q1 | $2.05M | Sell |
69,754
-578,804
| -89% | -$16.1M | ﹤0.01% | 2455 |
|
|
2015
Q4 | $21.4M | Buy |
648,558
+8,334
| +1% | +$272K | 0.01% | 1118 |
|
|
2015
Q3 | $23.1M | Buy |
640,224
+71,015
| +12% | +$3.05M | 0.01% | 1067 |
|
|
2015
Q2 | $25.6M | Sell |
569,209
-9,668
| -2% | -$376K | 0.01% | 1103 |
|
|
2015
Q1 | $17.7M | Buy |
578,877
+483,067
| +504% | +$18.8M | 0.01% | 1250 |
|
|
2014
Q4 | $4.87M | Buy |
95,810
+19,925
| +26% | +$892K | ﹤0.01% | 1928 |
|
|
2014
Q3 | $3M | Buy |
75,885
+384
| +0.5% | +$15.3K | ﹤0.01% | 2278 |
|
|
2014
Q2 | $3.25M | Buy |
75,501
+49,939
| +195% | +$1.9M | ﹤0.01% | 2271 |
|
|
2014
Q1 | $1.02M | Buy |
+25,562
| New | +$929K | ﹤0.01% | 3015 |
|
Other funds holding ENTA
FCM
KAM
DTC
VCM
VPM
SSC
Invesco's ENTA Position: Q1 2026 in Review
Invesco reduced its Enanta Pharmaceuticals (ENTA) stake by 28% in Q1 2026, selling an estimated $963K and leaving 182,002 shares worth $2.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2482.
Invesco first reported a position in ENTA in Q1 2014 and has held it in 49 quarters since. The position peaked at $60.4M in Q3 2018. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.
- Invesco held 182,002 shares of Enanta Pharmaceuticals worth $2.3M as of Q1 2026.
- Invesco sold 71,809 Enanta Pharmaceuticals shares in Q1 2026, an estimated $963K.
- Enanta Pharmaceuticals made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #2482 holding.
- Invesco first reported a position in Enanta Pharmaceuticals in Q1 2014 and has held it in 49 quarters since.
- Invesco's Enanta Pharmaceuticals position peaked at $60.4M in Q3 2018.
- 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.